Heather has over 30 years’ experience gained at global companies such as Sanofi-Aventis, ImClone (Eli Lilly), Takeda, Tesaro (GSK), Idis, Clinigen, MyTomorrow’s and Inceptua. 

Heather is a recognized expert in navigating the dynamic global regulatory and compliance environment surrounding new drug approvals and is an operational leader with direct experience managing and directing the provision of services under Managed Access Programs (MAP).  Heather is a leading MAP Subject Matter Expert in the development, design and execution of global MAPs across multiple therapy areas including rare disease and oncology, incorporating Real-World Data/Evidence. 

Over the last 15+ years Heather has focused on global Managed Access. Heather played a significant role in the early development of the human ‘Managed Access’ space, holding several leadership roles in global early access helping physicians and their patients to access human treatments.   

Heather joined VMD Sciences LLC’s Advisory Board and as the global Head of Regulatory Affairs, bringing a wealth of experience gained from Human Managed Access to the veterinary space providing regulatory support in veterinary treatment access.